What Green Bioactives does

Green Bioactives Ltd is a Scottish plant cell-based biomanufacturing company that develops and produces high-value bioactive molecules for the cosmetics, pharmaceutical, food, and agriculture sectors. The company's core technology is a proprietary plant cell culture platform that utilizes plant vascular stem cells and natural plant biochemistry to produce target biomolecules sustainably, independent of seasonality, climate, or agricultural supply chains. The platform combines enabling technologies, expertise, and intellectual property to control the complete production process and increase yields of target molecules, with demonstrated applications including paclitaxel production for chemotherapy and sustainable cosmetic ingredient manufacturing.

The company originated from research at the University of Edinburgh and was established through the ICURe programme funded by Innovate UK in 2018-2019. It operates from a research lab at the Roslin Innovation Centre and headquarters at Pentlands Science Park in Penicuik, Scotland. The team is led by founder/CSO Gary Loake (former Edinburgh professor) and CEO David McElroy (experienced agbio entrepreneur), with senior leadership including CBO Chris Meaney, CFO John Craig, and Head of Operations Andy Hall-Ponselé.

Green Bioactives generates revenue through direct B2B sales of sustainably manufactured bioactive ingredients to enterprise customers in target industries, using a quote-based pricing model for bulk ingredient orders. The company pursues a horizontal go-to-market strategy across four verticals and relies on partnership-driven market access and its university spin-out heritage for credibility. To date, the company has raised a £2.6M seed round led by Eos Advisory LLP (December 2022) and secured up to £1.1M in grant funding from Scottish Enterprise (April 2025) to scale its technology for the cosmetics and personal care market.

Name

Green Bioactives

Legal name

Green Bioactives Ltd

Website

https://green-bioactives.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Green Bioactives is a Scottish plant cell-based biomanufacturing company that produces high-value bioactive molecules for cosmetics, pharmaceutical, food, and agriculture customers using proprietary plant stem cell culture technology.

Ownership category

akta.pro rank

Product category

Plant-based Biomanufacturing

NAICS

Medicinal and Botanical Manufacturing (325411)

SIC

Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)

akta.pro primary industry

Bio-based Pharmaceuticals, Nutraceuticals & Specialty Bioactives (EUAAAIAK)

akta.pro secondary industries

Bio-based Food & Flavor Ingredients (Non-fuel Co-products: sweeteners, organic acids, flavors) (EUAAAIAJ), Biostimulants & Plant Health Biologicals (Microbial/Non-microbial) (AFABAEAK)

Keywords

• Plant cell biomanufacturing
• Bioactive ingredients
• Plant natural products
• Sustainable cosmetics ingredients
• Pharmaceutical biomanufacturing

Headquarters

HQ city

Edinburgh

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Bioactive Ingredient Sales: Sale of sustainably manufactured plant bioactive molecules to cosmetics, pharmaceutical, food, and agricultural companies. Revenue generated through direct B2B sales of ingredients produced via the company's plant cell culture platform.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Green Bioactives operates a sustainable plant cell-based biomanufacturing platform that uses plant vascular stem cells and cell cultures, combined with natural plant biochemistry, to produce high-value bioactive molecules. The platform enables continuous, scalable production of plant-derived ingredients independent of seasonality, climate, or traditional agriculture, serving the cosmetics, pharmaceutical, food and beverage, and agricultural sectors.

Product overview

Green Bioactives offers a single unified product: its proprietary plant cell biomanufacturing platform. This platform leverages plant stem cell/cell culture technology combined with natural plant biochemistry to produce high-value bioactive molecules. The technology enables the company to control the complete biomanufacturing process to increase yields of target plant molecules, serving multiple industries including cosmetics, pharmaceuticals, food, and agriculture.

Differentiator

Problem solved

Functional benefit

Products and services

• Plant Cell Biomanufacturing Platform

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Four partnerships are on record, tiered core and minor.

• University of EdinburghcoreStrategic or Co-development PartnerGreen Bioactives originated from University of Edinburgh research. Founder Gary Loake was a Professor of Molecular Plant Sciences at the University. The company was established through the ICURe programme and maintains connections for ongoing research collaboration.
• Roslin Innovation CentrecoreStrategic or Co-development PartnerThe company opened its research lab at the Roslin Innovation Centre (RIC) in March 2020, indicating a strategic location partnership for R&D activities.
• IBioIC (Scottish Industrial Biotechnology Innovation Centre)minorStrategic or Co-development PartnerGreen Bioactives has received IBioIC grant funding and founder Gary Loake was a former governing Board member of IBioIC, a networking and support organisation connecting industry, academia and government.
• Edinburgh InnovationsminorStrategic or Co-development PartnerCompany worked with Edinburgh Innovations, the university's commercialization arm. Former team member Samuel Casasola-Zamora was a PhD Tech Transfer Intern at Edinburgh Innovations before joining GBL.

Scale indicators3 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Plant Advanced Technologies (PAT): French plant-derived bioactive ingredient company using proprietary plant cell culture and aeroponic cultivation to produce high-value specialty molecules for cosmetics, pharma and nutraceuticals. Directly comparable as a smaller plant cell culture platform pursuing the same bioactive-molecule markets.
• Mibelle Biochemistry: Swiss pioneer of plant cell culture technology for cosmetic active ingredients (e.g., PhytoCellTec line), producing plant stem cell-derived actives for personal care brands. Closest direct peer in plant cell culture manufacturing for high-value bioactive cosmetic ingredients.
• Conagen: US synthetic biology company developing ingredients via fermentation for food, flavor, fragrance, cosmetics and pharma customers. Comparable as a biomanufacturing platform producing plant-equivalent bioactive molecules via cell-based processes, though Conagen relies on microbial rather than plant cell cultures.
• Codexis: US-listed enzyme engineering and biocatalysis company with pharmaceutical manufacturing and sustainable manufacturing lines. Comparable as a cell-based biomanufacturing platform producing high-value specialty molecules via engineered biological processes.

Emerging players

• LanzaTech: Carbon-to-product biomanufacturing platform using engineered microbes to produce fuels, chemicals and ingredients. Comparable as a gas/feedstock-to-bioproducts platform with similar GTM motion of selling sustainable ingredients to major CPG and industrial customers.

Broad incumbents

• Amyris: Synthetic biology company producing plant-derived ingredients (squalane, Reb M, etc.) for cosmetics, flavors and nutraceuticals via yeast fermentation. Comparable ingredient portfolio and customer segments, though Amyris has broader product breadth and a more difficult commercial trajectory.
• Croda International: FTSE-listed specialty ingredients supplier with major botanical actives portfolio across personal care, pharma and crop care. Comparable as a buyer/seller of natural bioactives into the same cosmetics, pharma and agriculture customers Green Bioactives targets.
• Givaudan: Global flavors and fragrances leader with growing natural ingredients and bioactive molecule portfolio, including biotech-derived ingredients. Comparable as a large incumbent customer/competitor in cosmetic and nutraceutical bioactives.
• BASF: Global chemicals giant with a dedicated Biosolutions division producing plant-derived and fermentation-derived ingredients for cosmetics, crop protection and pharma. Comparable as a broad incumbent with overlapping biomanufacturing capabilities and customer reach.
• Evonik: German specialty chemicals company with a Next Generation Solutions / biosolutions portfolio producing biotech-derived ingredients for cosmetics, pharma and agriculture. Comparable as a broad incumbent with adjacent biomanufacturing platforms and global customer relationships.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/gbioactives
• Facebookfacebook.com/GreenBioactives
• LinkedInlinkedin.com/company/green-bioactives

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Green Bioactives